BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34702313)

  • 21. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
    Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
    J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
    Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
    Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 24. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer.
    Yang Y; Feng M; Bai L; Liao W; Zhou K; Zhang M; Wu Q; Wen F; Lei W; Zhang P; Zhang N; Huang J; Li Q
    J Transl Med; 2021 Sep; 19(1):391. PubMed ID: 34526059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated Long Noncoding RNA LINC01234 Predicts Unfavorable Prognosis for Colorectal Cancer and Negatively Correlates With KLF6 Expression.
    Jiang X; Zhu Q; Wu P; Zhou F; Chen J
    Ann Lab Med; 2020 Mar; 40(2):155-163. PubMed ID: 31650732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
    Ubink I; Bloemendal HJ; Elias SG; Brink MA; Schwartz MP; Holierhoek YCW; Verheijen PM; Boerman AW; Mathijssen RHJ; de Leng WWJ; de Weger RA; van Grevenstein WMU; Koopman M; Lolkema MP; Kranenburg O; Borel Rinkes IHM
    BMC Cancer; 2017 Apr; 17(1):282. PubMed ID: 28424071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Ubink I; van Eden WJ; Snaebjornsson P; Kok NFM; van Kuik J; van Grevenstein WMU; Laclé MM; Sanders J; Fijneman RJA; Elias SG; Borel Rinkes IHM; Aalbers AGJ; Kranenburg O
    Br J Surg; 2018 Jan; 105(2):e204-e211. PubMed ID: 29341165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 31. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
    Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
    Front Immunol; 2020; 11():980. PubMed ID: 32670264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
    Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
    Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
    Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
    J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
    Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
    Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
    Unseld M; Belic J; Pierer K; Zhou Q; Moser T; Bauer R; Piringer G; Gerger A; Siebenhüner A; Speicher M; Heitzer E; Prager GW
    Int J Cancer; 2021 Mar; 148(6):1452-1461. PubMed ID: 32949150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
    Peters NA; Constantinides A; Ubink I; van Kuik J; Bloemendal HJ; van Dodewaard JM; Brink MA; Schwartz TP; Lolkema MPJK; Lacle MM; Moons LM; Geesing J; van Grevenstein WMU; Roodhart JML; Koopman M; Elias SG; Borel Rinkes IHM; Kranenburg O
    Front Oncol; 2022; 12():969855. PubMed ID: 36147916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
    Li C; Zhou H
    Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.